Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Archives of Pathology & Laboratory Medicine
|
March 14, 1998
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L
N Tinari, C Natoli, N D'Ostilio, et al.
Digestive Diseases and Sciences
|
May 11, 1999
Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon
P L Almasio, V Di Marco, C Bonura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2007
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer
C Natoli, E Cianchetti, N Tinari, et al.
Molecular Biology and Evolution
|
November 27, 2019
Visual Opsin Diversity in Sharks and Rays
Nathan S Hart, Trevor D Lamb, Hardip R Patel, et al.
British Journal of Cancer
|
August 5, 2004
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study
C Ficorella, M F Morelli, E Ricevuto, et al.
Journal of Hematology & Oncology
|
October 31, 2019
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
E Krasniqi, G Barchiesi, L Pizzuti, et al.
Journal of Oncology
|
April 23, 2020
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation"
D Brocco, P Lanuti, P Simeone, et al.
Journal of Oncology
|
December 13, 2019
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation
D Brocco, P Lanuti, P Simeone, et al.
Breast (Edinburgh, Scotland)
|
August 1, 2016
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience
L Moscetti, P Vici, T Gamucci, et al.
Biomarker Research
|
July 14, 2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
E Krasniqi, A Sacconi, D Marinelli, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Archives of Pathology & Laboratory Medicine
|
March 14, 1998
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L
N Tinari, C Natoli, N D'Ostilio, et al.
Digestive Diseases and Sciences
|
May 11, 1999
Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon
P L Almasio, V Di Marco, C Bonura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2007
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer
C Natoli, E Cianchetti, N Tinari, et al.
Molecular Biology and Evolution
|
November 27, 2019
Visual Opsin Diversity in Sharks and Rays
Nathan S Hart, Trevor D Lamb, Hardip R Patel, et al.
British Journal of Cancer
|
August 5, 2004
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study
C Ficorella, M F Morelli, E Ricevuto, et al.
Journal of Hematology & Oncology
|
October 31, 2019
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
E Krasniqi, G Barchiesi, L Pizzuti, et al.
Journal of Oncology
|
April 23, 2020
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation"
D Brocco, P Lanuti, P Simeone, et al.
Journal of Oncology
|
December 13, 2019
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation
D Brocco, P Lanuti, P Simeone, et al.
Breast (Edinburgh, Scotland)
|
August 1, 2016
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience
L Moscetti, P Vici, T Gamucci, et al.
Biomarker Research
|
July 14, 2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
E Krasniqi, A Sacconi, D Marinelli, et al.
Page
of 10